Cargando…

Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents

A series of quinazolinone derivatives (7a–7h) were synthesized as antiproliferative agents. All compounds, were synthesized through three steps method and structurally evaluated by FTIR, (1)H-NMR, (13)CNMR and Mass spectroscopy. Their cytotoxic activities were assessed using MTT protocol against thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Emami, Leila, Khabnadideh, Soghra, Faghih, Zahra, Farahvasi, Farnoosh, Zonobi, Fatemeh, Gheshlaghi, Saman Zare, Daili, Shadi, Ebrahimi, Ali, Faghih, Zeinab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682696/
https://www.ncbi.nlm.nih.gov/pubmed/36419100
http://dx.doi.org/10.1186/s13065-022-00893-z
Descripción
Sumario:A series of quinazolinone derivatives (7a–7h) were synthesized as antiproliferative agents. All compounds, were synthesized through three steps method and structurally evaluated by FTIR, (1)H-NMR, (13)CNMR and Mass spectroscopy. Their cytotoxic activities were assessed using MTT protocol against three humans cancerous (MCF-7, A549 and 5637) and normal (MRC-5) cell lines. In addition, molecular docking and simulation studies of the synthesized compounds were performed to assessment their orientation, interaction mode against EGFR as plausible mechanism of quinazoline compounds as anticancer agents. The synthesized compounds mostly showed moderate activity against the three studied cell lines. They also indicated an appropriate selectivity against tumorigenic and non-tumorigenic cell line. The molecular docking results also confirmed biological activity. Most of the compounds fulfilled Lipinski rule. Collectively, these compounds with further modification can be considered as potent antiproliferative agents. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-022-00893-z.